Zum Inhalt springen
Sponsorship
Die MVF-Knowledge-HubsFrisch aus der Forschung. Täglich aktualisiert!

Suchen Sie in Hunderten nationaler und internationaler Datenbanken nach dem neuesten Studienwissen der angegebenen Themengebiete und/oder lassen Sie sich werktäglich per Newsletter informieren. Die Newsfeeds werden auf deutsch übersetzt and nach Übertragbarkeit auf das deutsche Gesundheits-/Versorgungssystem ausgewählt:

Zu den Knowledge-Hubs

“Domestic violence”: Parents stab child 17,000 times

Sensor-assisted pump therapy (SuP) has existed since 2006 by combining insulin pumps and continuous glucose monitoring, or CGM for short. While this new form of therapy is being prescribed to a much greater extent, especially for type 1 diabetics in other European countries, there is already general reimbursement in the Netherlands, Switzerland, Israel, Slovenia, Sweden, Ireland, Slovakia, Estonia and Austria exists, penetration in Germany is rather low. Because CGM is currently not reimbursable in this country - so each health insurance company decides on a case-by-case basis. On November 23rd last year, the G-BA commissioned IQWiG, which published a preliminary report plan on “Continuous glucose measurement with real-time measuring devices” on April 18th this year, which was published on July 20th after a hearing on July 9th. was finalized in October. This is now the basis of a preliminary assessment that will be published in the first quarter of 2014, which will then be submitted for hearing again. Only then – in the third quarter of next year – will the G-BA decide on reimbursement eligibility.

Read more
First publication date: 28.05.2013

Additional Information

Plain Text

>> Continuous glucose monitoring (CGM) is not yet reimbursable in this country - so each health insurance company decides on a case-by-case basis. On November 23rd last year, the G-BA commissioned IQWiG, which published a preliminary report plan on “Continuous glucose measurement with real-time measuring devices” on April 18th this year, which was published on July 20th after a hearing on July 9th. was finalized in October.
This is now the basis of a preliminary assessment that will be published in the first quarter of 2014, which will then be submitted for hearing again. Only then – in the third quarter of next year – will the G-BA decide on reimbursement eligibility.
Perhaps then the martyrdom of the Abel family, who, at the invitation of the Medtronic company, took part in a panel discussion entitled “How much technology should there be in diabetes therapy?” – More patient autonomy with CGM?” illustrated what it means to have two small children with type 1 diabetes in the family. Neither mother nor father nor the two children have slept through the night for years. Blood sugar must be measured every two hours by parents pricking their child's fingertip with a mini lancet, placing a drop of blood on a measuring stick, starting the measuring process and then programming the required amount of insulin in the pump. A work that could be done by a glucose sensor placed independently in the subcutaneous fatty tissue by the patient, which continuously measures the glucose level every few minutes, which is then shown on the display of the insulin pump, which regularly delivers insulin and, in the event of impending hypoglycemia, in front of the person affected. But especially in children whose parents have a deep-seated fear, you can switch off completely for a limited time - because convulsions, coma or even death can be the result from 2, and certainly with more than 4 hours of low blood sugar. But the parents continue to prick their two children more than 17,000 times since they were diagnosed with type 1 diabetes, 13,000 of them at night. By the time the G-BA finally decides, there will probably be a few thousand small stitches that will scar the little fingertips a little more. Or even a few hundred thousand times if the Federal Committee does not recognize the reimbursement. The Abel family's health insurance company, a smaller BKK, does not reimburse sensor-assisted pump therapy.

...

Do you want to leave us already?

Subscribe to our newsletter quickly. Then you can be sure that you won't miss anything.